Announced details
The company conducts joint research with the Nagasaki Laboratory at Kyushu University.
The Biomedical Information Analysis division of the Center for Deep Omics Science, Institute of Health Sciences, Kyushu University. The person in charge is Professor Nagasaki Masao (長﨑 正朗).
Montreal, Canada: Palais des congrès de Montréal (venue for ASHG 2026)
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
Official website of the American Society of Human Genetics (ASHG) (https://ashgmeeting.ashg.org/)
| Item | Details |
|---|---|
| Names of Products / Services Covered | Quantum machine learning model QTFPred (Quantum-based Transcription Factor Predictor), Transcription factor binding prediction model using a GPU-efficient quantum machine learning implementation, Gene-level haplotype phasing using spectral MAX-CUT on a lead-level graph |
| Counterparty | Kyushu University, Institute of Health Sciences, Center for Deep Omics Science, Biomedical Information Analysis, Nagasaki Laboratory |
| Counterparty overview | The Biomedical Information Analysis division of the Center for Deep Omics Science, Institute of Health Sciences, Kyushu University. The person in charge is Professor Nagasaki Masao (長﨑 正朗). |
| Relationship with the Company | The company conducts joint research with the Nagasaki Laboratory at Kyushu University. |
| Launch date | From 20 October 2026 to 24 October 2026 (actual; ASHG 2026 venue and poster presentations) |
| Applicable area | Drug Discovery, Personalized Medicine, Disease risk prediction, Drug target molecule discovery, Genomic analysis, Medical and drug discovery research |
| Location | Montreal, Canada: Palais des congrès de Montréal (venue for ASHG 2026) |
| Source | Official website of the American Society of Human Genetics (ASHG) (https://ashgmeeting.ashg.org/) |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To pursue the implementation in society and broad applications of quantum AI and genome analysis technologies through the publication of research findings, and to contribute to sustained technological innovation and the resolution of social issues.